Skip to main content
Clinical Trials/IRCT20200803048288N1
IRCT20200803048288N1
Completed
Phase 3

Comparative study of the effect of Haloperidol and Dexmedetomidine on delirium and agitation in mechanically ventilated patients following concussion admitted to the intensive care unit

Ahvaz University of Medical Sciences0 sites60 target enrollmentStarted: TBDLast updated:

Overview

Phase
Phase 3
Status
Completed
Enrollment
60

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 65 years (—)
Sex
All

Inclusion Criteria

  • APACHE II criteria more than 48
  • RASS criteria between \+1 to \+4
  • At least 48 hours after hospitalization in the intensive care unit

Exclusion Criteria

  • Dissatisfaction of the patient's legal guardian
  • Patients who are candidates for surgery
  • Unstable hemodynamic status
  • History of mental illness or use of neuroleptics
  • History of drug use any contraindications to Dexmedetomidine or Haloperidol (Allergy, Parkinson's, Hypotension, BradyCardiac)
  • Renal or Hepatic Fysfunction

Investigators

Similar Trials